COMMUNIQUÉS West-GlobeNewswire

FDA Alignment to Advance ProstACT Global Phase 3 Trial
02/07/2026
FDA and Telix align on advancement into Part 2 of the ProstACT Global Phase 3 study in the United States. FDA agrees with the clinical protocol and proposed statistical framework across three standard-of-care [...]
Junshi Biosciences Enters Licensing Collaboration with Fosun Wanbang on Roconkibart (IL-17A)
02/07/2026
SHANGHAI, July 01, 2026 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, [...]
GNI Group Completes Acquisition of AYUMI Pharmaceutical
02/07/2026
Japan-Originated Global Biopharma Company Founded in 2001 Enters Its “Second Founding Phase” TOKYO, July 01, 2026 (GLOBE NEWSWIRE) -- GNI Group Ltd. (TSE: 2160, “GNI Group” or the “Company”) today announced that it has [...]
PDS Health Surpasses Five Million CEREC Chairside Restorations with Dentsply Sirona, Marking a Major Milestone in Scaled Digital Dentistry
01/07/2026
This milestone reflects PDS Health’s continued investment in digital technologies that help practices operate more efficiently, expand access to same-day restorative care and deliver a more consistent experience for [...]
Range Impact and C2 Ventures Launch AI Infrastructure Platform on 9,000-Acre West Virginia Energy Corridor
01/07/2026
Platform combines strategic land, power, water, and transportation infrastructure to support next-generation AI and hyperscale computing. CLEVELAND, OHIO, July 01, 2026 (GLOBE NEWSWIRE) -- Range Impact, Inc. (OTCQB: [...]
Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
01/07/2026
NEW YORK, July 01, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on July 1, 2026, the Company [...]
Fate Therapeutics to Participate in Upcoming Third Quarter 2026 Conferences
01/07/2026
SAN DIEGO, July 01, 2026 (GLOBE NEWSWIRE) --  Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)- [...]
Damora Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/07/2026
BOSTON, July 01, 2026 (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (NASDAQ: DMRA) (“Damora”), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today announced that it [...]
Candel Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
01/07/2026
NEEDHAM, Mass., July 01, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal immunotherapies to improve [...]
FDA Approves First Gene Therapy for Young Children with Sickle Cell Disease
02/07/2026
State-of-the-art gene therapy provides new treatment option for children 2 years and older with life-threatening blood disorder Silver Spring, MD, July 01, 2026 (GLOBE NEWSWIRE) -- The U.S. Food and Drug Administration [...]
Memphis Surgeon Seeks to Overturn Conviction, Citing FDA Guidance on Medical Devices with National Experts Aghast at Overzealous Persecution Despite FDA Safe Harbor
01/07/2026
Sworn Declarations from Former FDA Counsel and Renowned Device Regulation Expert Expose Clear Regulatory Carve-Outs for Outpatient Clinics; Emergency Motion Seeks to Strike Verdict Before July 7 Sentencing MEMPHIS, Tenn [...]
She Had No Clue, Until She Did: Clue's new campaign spotlights seven women who found the missing piece behind years of symptoms, questions and hormonal uncertainty
01/07/2026
LONDON, July 01, 2026 (GLOBE NEWSWIRE) -- A PMOS diagnosis that finally made sense. The realisation that anxiety wasn't random after all. A conception journey that suddenly felt less overwhelming. She Had No Clue, Until [...]
Vaxart Enters Cooperation Agreement with Stockholder Group and Announces Board and Corporate Governance Enhancements
01/07/2026
Company to Appoint Mutually Agreed Upon Independent Director; Forms Stockholder Engagement and Clinical and Regulatory Affairs Committees Stockholder Group Withdraws Director Nominations SOUTH SAN FRANCISCO, Calif., [...]
FDA Approves New Treatment That Uses Donor Immune Cells to Prevent Serious Complications in Blood Cancer Patients
01/07/2026
Novel allogeneic T-cell-based immunotherapy reduces chronic graft-versus-host disease (GVHD) in patients with blood cancers undergoing stem cell transplantation Silver Spring, MD, July 01, 2026 (GLOBE NEWSWIRE) -- The U [...]
Safe Legal Steroid Alternatives: CrazyBulk Announces 2026 Legal Steroids For Muscle Growth and Strength Available In USA
01/07/2026
Discover CrazyBulk's safe legal steroid alternatives designed to support muscle growth, bulking, cutting, strength, and bodybuilding with science-inspired formulas. New York City, July 01, 2026 (GLOBE NEWSWIRE) -- In [...]
Rentschler Biopharma appoints Dr. Torsten Woehr as Chief Executive Officer
01/07/2026
Laupheim, Germany, and Milford, MA, USA, July 01, 2026 (GLOBE NEWSWIRE) -- Rentschler Biopharma appoints Dr. Torsten Woehr as Chief Executive Officer Dr. Torsten Woehr brings over 25 years of CDMO experience with strong [...]
Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace
01/07/2026
CHICAGO, July 01, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has repurchased 2, [...]
Managing Mental Health During the Summer
01/07/2026
Park Mental Health experts share strategies for how to protect mental, emotional wellness and manage the busy season San Diego, CA, July 01, 2026 (GLOBE NEWSWIRE) -- Summer is officially here and families are busy [...]
PolarityBio Announces Submission of its Biologics License Application for SkinTE® for the Treatment of Wagner Grade 1 Diabetic Foot Ulcers
01/07/2026
SkinTE ® would be the first new biologic commercially available in the U.S. for the treatment of a common chronic wound indication in nearly 30 years, if approved. SkinTE ® is a first-in-class autologous cutaneous [...]

Pages